• A unique collection of 2819 approved drugs and API included in pharmacopoeia for high throughput screening (HTS) and high content screening (HCS).
• All drugs were from approved institutions such as FDA,EMA,HMA,CFDA,PMDA,or pharmacopoeia such as USP,BP,EP,JP,Ph.Int,etc.
• Provides the New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) information of FDA approved drugs.
• Locate new targets for old drugs.
• Bioactivity and safety confirmed by clinical trials.
• Related to oncology, cardiology, anti-inflammatory, immunology, neuropsychiatry, analgesia etc.
• Structurally diverse, medicinally active, and cell permeable.
FDA-approved Drug Library (FDA上市分子库)
目录号: GL10001纯度: >98%
2819种药典中收录的批准药物和API的独特集合，用于高通量筛选(HTS)和高内涵筛选(HCS)。
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 20uL (96-well Microplate) | ¥18,000.00 | 现货 | 1 | |
| 100uL (96-well DeepWell) | ¥54,000.00 | 现货 | 1 | |
| 10uL (96-well Microplate) | ¥10,000.00 | 现货 | 1 | |
| 100uL (96-well Racks with Screw Cap) | ¥67,500.00 | 现货 | 1 |
电话: 400-920-5774Email: sales@glpbio.cn
文献被引
本产品暂无引用记录;以下为 GlpBio 产品在 Nature / Cell / Science 等顶刊的客户引用样例
Nature641, 529–536 (2025)
Nature628, 630–638 (2024)
Nature632, 686–694 (2024)
Nature618, 1017–1023 (2023)
Nature610, 366–372 (2022)
Cell187(9):2288-2304 (2024)
Cell183(7):1867-1883 (2020)
Science388(6745) (2025)
Science387(6739) (2025)
Science387(6734) (2025)
Cell Research35, 97–116 (2025)
Cell Research34, 683–706 (2024)
Cell Research33, 273–287 (2023)
Cell Research33, 546–561 (2023)
Cell Research33, 904–922 (2023)
Cell Research31, 1291–1307 (2021)
产品描述 Description
产品文档 Product Documents
Purity:>98%